NCT05570734 Latinos Understanding the Need for Adherence in Diabetes Using E-Health
| NCT ID | NCT05570734 |
| Status | Recruiting |
| Phase | — |
| Sponsor | San Diego State University |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2023-02-27 |
| Primary Completion | 2025-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2023-02-27 with a primary completion date of 2025-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Latinos Understanding the Need for Adherence in Diabetes using Care Coordination, Integrated Medical and Behavioral Care and E-Health (LUNA-E) is a randomized controlled trial (RCT) that will test the effectiveness a patient-centered, team-based, primary care intervention with E-Health enhancements in improving glycemic control (primary outcome, hemoglobin A1C level) and psychological distress (secondary outcome; depression, anxiety symptoms).
Eligibility Criteria
Inclusion Criteria: 1. Self identify as Hispanic/Latino ethnicity of any race 2. Registered patient of federally qualified health center 3. 18 years of age or older 4. Type 2 diabetes with hemoglobin A1C (HbA1c) \>7.5% in past 90 days 5. Approval from primary care provider 6. Not currently enrolled/participating in any other diabetes intervention program(s) Exclusion Criteria: 1. Actively being treated for cancer or Parkinson's Disease 2. Pregnant or nursing (temporary exclusion, may qualify 6-months postpartum) 3. Have plans to move out of the area in the next 12 months 4. Have other existing mental or physical health problems so severe as to prohibit informed consent and participation 5. Have severe diabetes complications (e.g., renal disease, or on dialysis)
Contact & Investigator
Gregory A Talavera, MD/MPH
PRINCIPAL INVESTIGATOR
San Diego State University
Frequently Asked Questions
Who can join the NCT05570734 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05570734 currently recruiting?
Yes, NCT05570734 is actively recruiting participants. Contact the research team at pmendoza@sdsu.edu for enrollment information.
Where is the NCT05570734 trial being conducted?
This trial is being conducted at Chula Vista, United States.
Who is sponsoring the NCT05570734 clinical trial?
NCT05570734 is sponsored by San Diego State University. The principal investigator is Gregory A Talavera, MD/MPH at San Diego State University. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.